BIOCRYST PHARMACEUTICALS INC (36) | Uncategorized (10)

Recent Contracts

Amendment, dated August 31, 2020, to the Contract dated September 1, 2018 between BioCryst Pharmaceuticals, Inc. and the Department of Health and Human Services (Filed With SEC on September 3, 2020)
Cash and cash equivalents (Filed With SEC on May 11, 2020)
Cash and cash equivalents (Filed With SEC on May 11, 2020)
Drug/Drug Candidate (Filed With SEC on March 13, 2020)
Drug/Drug Candidate (Filed With SEC on March 13, 2020)
Cash and cash equivalents (Filed With SEC on November 8, 2019)
Cash and cash equivalents (Filed With SEC on November 8, 2019)
Amendment dated as of September 23, 2019 to the Contract dated September 1, 2018 between BioCryst Pharmaceuticals, Inc. and the Department of Health and Human Services (Filed With SEC on September 26, 2019)
Cash and cash equivalents (Filed With SEC on August 8, 2019)
Cash and cash equivalents (Filed With SEC on May 9, 2019)